|Bid||70.04 x 1100|
|Ask||70.08 x 800|
|Day's Range||69.03 - 70.18|
|52 Week Range||63.92 - 88.78|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||76.16|
|Forward Dividend & Yield||0.21 (0.30%)|
|Ex-Dividend Date||May 03, 2022|
|1y Target Est||85.83|
Subscribe to Yahoo Finance Plus to view Fair Value for ALC
Alcon's (ALC) robust innovation pipeline is delivering solid results as evidenced by the successful launch of new ATIOL roles and SiHy contact lenses.
GENEVA, August 09, 2022--Alcon Reports Second Quarter 2022 Results
Robust retail and pharmacy sales performance are likely to have driven CVS Health's (CVS) Q2 performance.